Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2025-12-28 @ 11:51 AM
Study NCT ID:
NCT06089356
Status:
UNKNOWN
Last Update Posted:
2023-10-18
First Post:
2023-10-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Zolmitriptane as Prophylaxis for Chilhood Migraine
Sponsor:
Tanta University
Organization:
Study Overview
Official Title:
Zolmitriptane as Prophylactic Therapy Childhood Migraine
Status:
UNKNOWN
Status Verified Date:
2023-10
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
zolmitriptane can be tried as prophylactic therapy of childhood migraine
Detailed Description:
90 children with migraine included in the study first group 30 received zolmitriptane second group 30 received topiramate third group 30 received valproate
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: